AT442862T
Reduced-viscosity concentrated protein formulations
Abstract
stable liquid formulation comprising an immunoglobulin in an amount of at least 80 mg / ml and a salt and / or buffer in an amount of at least 100 mM, and having a kinematic viscosity of 50 mm 2 / s or less at 25 .
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
43 members in 14 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 24010700 | United States of America | P | |
| 29383401 | United States of America | P | |
| 0142487 | United States of America | W |
Members43
| Document | Office | Kind | |
|---|---|---|---|
| CA2423227A1 | Canada | A1 | |
| CA2751188A1 | Canada | A1 | |
| US2002045571A1 | United States of America | A1 | |
| WO0230463A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1344102A | Australia | A | |
| WO0230463A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1324776A2 | European Patent Office (EPO) | A2 | |
| IL155002A0 | Israel | A0 | |
| JP2004532798A | Japan | A | |
| US6875432B2 | United States of America | B2 | |
| US2005175603A1 | United States of America | A1 | |
| AU2002213441B2 | Australia | B2 | |
| US2007116700A1 | United States of America | A1 | |
| JP2009167190A | Japan | A | |
| EP1324776B1 | European Patent Office (EPO) | B1 | |
| JP4340062B2 | Japan | B2 | |
| AT442862TThis record | Austria | T | |
| ATE442862T2 | Austria | T2 | |
| DE60139944D1 | Germany | D1 | |
| EP2116265A2 | European Patent Office (EPO) | A2 | |
| PT1324776E | Portugal | E | |
| DK1324776T3 | Denmark | T3 | |
| SI1324776T1 | Slovenia | T1 | |
| ES2332402T3 | Spain | T3 | |
| US7666413B2 | United States of America | B2 | |
| EP2116265A3 | European Patent Office (EPO) | A3 | |
| CA2423227C | Canada | C | |
| US8142776B2 | United States of America | B2 | |
| US2012076783A1 | United States of America | A1 | |
| US8703126B2 | United States of America | B2 | |
| IL231675A0 | Israel | A0 | |
| US2015044198A1 | United States of America | A1 | |
| CY1110547T1 | Cyprus | T1 | |
| IL155002A | Israel | A | |
| US2016367675A1 | United States of America | A1 | |
| IL231675A | Israel | A | |
| EP1324776B2 | European Patent Office (EPO) | B2 | |
| ES2332402T5 | Spain | T5 | |
| DK1324776T4 | Denmark | T4 | |
| SI1324776T2 | Slovenia | T2 | |
| US10166293B2 | United States of America | B2 | |
| US2019231875A1 | United States of America | A1 | |
| EP2116265B1 | European Patent Office (EPO) | B1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 1981824
Titles2
- German
- NIEDERVISKOSE KONZENTRIERTE PROTEINFORMULIERUNGEN
- English
- LOW VISCOSIS CONCENTRATED PROTEIN FORMULATIONS
Classification
- CPC, 7
- A61K39/39591
- A61K9/0019
- A61K47/02
- A61K47/12
- A61K47/183
- Y10S435/80
- A61K47/26
- IPC, 8
- A61K9 08
- A61K47 02
- A61K38 00
- A61K38 16
- A61K39 395
- A61K47 12
- A61K47 18
- A61K47 26